株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の薬物乱用検査市場:産業分析、規模、シェア、成長率、動向、予測

Drugs of Abuse Testing Market (Analyzers (Immunoassays Analyzers, Chromatographic Devices, Breath Analyzers), Rapid Testing Devices) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

発行 Transparency Market Research 商品コード 294620
出版日 ページ情報 英文 172 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.53円で換算しております。
Back to Top
世界の薬物乱用検査市場:産業分析、規模、シェア、成長率、動向、予測 Drugs of Abuse Testing Market (Analyzers (Immunoassays Analyzers, Chromatographic Devices, Breath Analyzers), Rapid Testing Devices) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
出版日: 2016年12月06日 ページ情報: 英文 172 Pages
概要

世界の薬物市場は、2015年の41億米ドルから、2024年末までに64億米ドルに達すると予測されています。市場は、2016年〜2024年のCAGR (複合年間成長率) で、5.3%の成長が予測されています。

当レポートでは、世界の薬物乱用検査市場について調査分析し、産業分析、市場規模と予測、セグメント別の市場分析、地域別の市場分析、競合情勢など、体系的な情報を提供しています。

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 規制シナリオ
  • 市場力学
  • 市場収益予測
  • 市場見通し
  • ファイブフォース分析
  • バリューチェーン分析
  • 技術評価
  • 世界の需給シナリオ

第5章 世界の薬物乱用検査市場の分析と予測:製品タイプ別

  • イントロダクション
  • 製品比較マトリクス
  • 市場収益シェアと魅力分析:製品タイプ別
  • 市場規模予測:製品タイプ別

第6章 世界の薬物乱用検査市場の分析と予測:標本タイプ別

  • イントロダクション
  • 市場収益シェアと魅力分析:標本タイプ別
  • 市場規模予測:標本タイプ別

第7章 世界の薬物乱用検査市場の分析と予測:検査タイプ別

  • イントロダクション
  • 市場収益シェアと魅力分析:検査タイプ別
  • 市場規模予測:検査タイプ別

第8章 世界の薬物乱用検査市場の分析と予測:エンドユーザー別

  • イントロダクション
  • 市場収益シェアと魅力分析:エンドユーザー別
  • 市場規模予測:エンドユーザー別

第9章 世界の薬物乱用検査市場の分析と予測:地域別

  • 市場収益シェアと魅力分析:地域別
  • 市場規模予測:地域別

第10章 北米の薬物乱用検査市場の分析と予測

  • 市場概要
  • 市場価格シェア分析:製品タイプ別
  • 市場価格シェア分析:標本タイプ別
  • 市場価格シェア分析:検査タイプ別
  • 市場価格シェア分析:エンドユーザー別
  • 市場価格シェア分析:国別
  • 市場規模予測
  • 市場の魅力分析

第11章 ラテンアメリカの薬物乱用検査市場の分析と予測

  • 市場概要
  • 市場価格シェア分析:製品タイプ別
  • 市場価格シェア分析:標本タイプ別
  • 市場価格シェア分析:検査タイプ別
  • 市場価格シェア分析:エンドユーザー別
  • 市場価格シェア分析:国別
  • 市場規模予測
  • 市場の魅力分析

第12章 欧州の薬物乱用検査市場の分析と予測

  • 市場概要
  • 市場価格シェア分析:製品タイプ別
  • 市場価格シェア分析:標本タイプ別
  • 市場価格シェア分析:検査タイプ別
  • 市場価格シェア分析:エンドユーザー別
  • 市場価格シェア分析:国別
  • 市場規模予測
  • 市場の魅力分析

第13章 アジア太平洋地域の薬物乱用検査市場の分析と予測

  • 市場概要
  • 市場価格シェア分析:製品タイプ別
  • 市場価格シェア分析:標本タイプ別
  • 市場価格シェア分析:検査タイプ別
  • 市場価格シェア分析:エンドユーザー別
  • 市場価格シェア分析:国別
  • 市場規模予測
  • 市場の魅力分析

第14章 中東・アフリカの薬物乱用検査市場の分析と予測

  • 市場概要
  • 市場価格シェア分析:製品タイプ別
  • 市場価格シェア分析:標本タイプ別
  • 市場価格シェア分析:検査タイプ別
  • 市場価格シェア分析:エンドユーザー別
  • 市場価格シェア分析:国別
  • 市場規模予測
  • 市場の魅力分析

第15章 競合情勢

  • 市場企業
  • 市場シェア分析:国別
  • 企業プロファイル
    • F. Hoffmann La-Roche Ltd
    • Siemens Healthineers (Siemens AG)
    • Thermo Fisher Scientific, Inc.
    • Alere, Inc.
    • 島津製作所
    • Laboratory Corporation of America Holdings
    • Dragerwerk AG & Co. KGaA
    • Express Diagnostics International Inc.

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Global Drugs of Abuse Testing Market: Snapshot

Drugs of abuse testing offer a variety of testing methods that can be conducted at home as well as in laboratories to detect drugs present in the human body. These drugs are tested through saliva, blood, and sweat. The testing of drugs is done for drugs that are banned by governments. Analysts anticipate that the global market will witness a considerable growth rate in the coming years due to rising prevalence of drug abuse. According to the research report, the global drugs is projected to reach US$6.4 bn by the end of 2024 as against US$4.1 bn in 2015. During the forecast years of 2016 and 2024, the global market is estimated to progress at a CAGR of 5.3%.

image1

Rise in Drug Abuse Ensures Swift Uptake of Testing Products

The global market for drugs of abuse testing has witnessed a prolific growth over the past few years due to the increasing abuse of illicit drugs and alcohol in various parts of the world. The harmful effects of drug abuse to the society has been the primary growth driver for the increasing uptake of drugs of abuse testing products. The market is also thriving due to emergence of testing laboratories in recent times. The growing pressure on the corporate world to ensure that the work environment is safe for their employees and devoid of illicit activities, offices across the globe are also conducting workplace screening. Analysts predict the growing number initiatives by governments across the globe along with non-profit organization to reduce the levels of drug abuse will have a positive impact on the overall market.

The global drugs of abuse testing market uses samples such as breath, saliva, sweat, urine, blood, and hair to test for presence of drugs in the human body. Of all these, the urine sample type segment accounted for a lion's share in the global market of 43.8% in 2015. The saliva sample type segment followed next with a share of 24.2% in the overall market in 2015.

On the basis of testing type the global drugs of abuse market is segmented into criminal justice testing, pain management testing, and work place screening. As of 2015, the criminal justice testing segment held a share of 39.7% in the overall market. Amongst the end users, the forensic laboratories segment held a leading share of 42.5% in the global drugs of abuse testing market in 2015.

Stringent Government Norms across North America Boost Regional Market

In terms of geography, the global market is divided into Asia Pacific, Latin America, the Middle East and Africa, Europe, and North America. Of these North America held a mammoth share in the global market. The regional market accounted for 49.3% of the overall market due to stringent rules pertaining to the use of illicit drugs. Europe is also anticipated to show a steady growth rate in the overall market due to high incidence of abuse of prescription drugs.

The research report profiles some of the leading companies operating in the global drugs of abuse testing market and provides a thorough explanation of their financial outlook, research and development activities, and business and marketing strategies. The key players identified in the global market are Laboratory Corporation of America Holdings, Alere Inc., Roche Diagnostics, Thermo Fisher Scientific Inc., Siemens Healthcare, Drägerwerk AG & Co. KGaA, Shimadzu Corporation, and Express Diagnostics International Inc.

Report Description

Global Drugs of Abuse Testing Market: Scope and Methodology

This report on the global drugs of abuse testing market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global drugs of abuse testing market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global drugs of abuse testing market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of product and product features of different types. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing demand for drug abuse testing in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Drugs of Abuse Testing Market: Segmentation

Based on product type, the global drugs of abuse testing market has been segmented three major sub segments namely, analyzers, rapid testing devices and consumables. The analyzers product type segment is further sub - segmented into immunoassay analyzers, chromatographic devices and breath analyzers. The rapid testing devices product type segment is further sub segmented into urine testing devices and oral fluid testing devices. The consumables product type segment is further sub - segmented into fluid collection devices and others. The market has been further studied from the point of view of sample type.

Based on sample type, the market has been segmented into saliva, breath, urine, blood, hair & sweat. On the basis of testing type, the market has been segmented into pain management testing, criminal justice testing and work place screening. Based on the end users the market is categorized into hospitals, diagnostics laboratories, on-the-spot testing and forensic laboratories.

Drugs of Abuse Testing Market: Geographical Outlook

Geographically, the global drugs - of - abuse testing market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, Russia, China, Japan, India, Australia & New Zealand, GCC Countries, South Africa, Brazil, and Mexico.

Key Players Mentioned in the Report are:

The report also profiles major players in the drugs of abuse testing market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Alere Inc., Laboratory Corporation of America Holdings, Roche Diagnostics, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, Siemens Healthcare, Express Diagnostics International Inc. and Shimadzu Corporation.

The global drugs of abuse testing market has been segmented as follows:

Global Drugs of Abuse Testing Market, by Product Type

  • Analyzers
    • Immunoassays Analyzers
    • Chromatographic Devices
    • Breath Analyzers
  • Rapid Testing Devices
    • Urine Testing Devices
    • Oral Fluid Testing Devices
  • Consumables
    • Fluid Collection Devices
    • Others

Global Drugs of Abuse Testing Market, by Sample Type

  • Saliva
  • Breath
  • Urine
  • Blood
  • Hair & Sweat

Global Drugs of Abuse Testing Market, by Testing Type

  • Pain Management Testing
  • Criminal Justice Testing
  • Work Place Screening

Global Drugs of Abuse Testing Market, by End User

  • Hospitals
  • Diagnostics Laboratories
  • On-the-spot Testing
  • Forensic Laboratories

Global Drugs of Abuse Testing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Drugs - of - Abuse Testing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Market Overview
  • 4.3. Regulatory Scenario
  • 4.4. Market Dynamics
    • 4.4.1. Drivers
    • 4.4.2. Restraints
    • 4.4.3. Opportunities
    • 4.4.4. Trends
  • 4.5. Market Revenue Projections (US$ Mn)
  • 4.6. Market Outlook
  • 4.7. Porter's Five Forces Analysis
  • 4.8. Value Chain Analysis
  • 4.9. Technology Assessment
  • 4.10. Global Demand and Supply Scenario

5. Global Drugs - of - Abuse Testing Market Analysis and Forecast, By Product Type

  • 5.1. Introduction
  • 5.2. Product Comparison Matrix
  • 5.3. Market Revenue Share (US$) and Attractiveness Analysis, By Product Type
  • 5.4. Market Size (US$ Mn) Forecast, By Product Type
    • 5.4.1. Analyzers
      • 5.4.1.1. Immunoassay Analyzers
      • 5.4.1.2. Chromatographic Devices
      • 5.4.1.3. Breath Analyzers
    • 5.4.2. Rapid Testing Devices
      • 5.4.2.1. Urine Testing Devices
      • 5.4.2.2. Oral Fluid Testing Devices
    • 5.4.3. Consumables
      • 5.4.3.1. Fluid Collection Devices
      • 5.4.3.2. Others

6. Global Drugs - of - Abuse Testing Market Analysis and Forecast, By Sample Type

  • 6.1. Introduction
  • 6.2. Market Revenue Share (US$) and Attractiveness Analysis, By Sample Type
  • 6.3. Market Size (US$ Mn) Forecast, By Sample Type
    • 6.3.1. Saliva
    • 6.3.2. Breath
    • 6.3.3. Urine
    • 6.3.4. Blood
    • 6.3.5. Hair & Sweat

7. Global Drugs - of - Abuse Testing Market Analysis and Forecast, By Testing Type

  • 7.1. Introduction
  • 7.2. Market Revenue Share (US$) and Attractiveness Analysis, By Testing Type
  • 7.3. Market Size (US$ Mn) Forecast, By Testing Type
    • 7.3.1. Pain Management Testing
    • 7.3.2. Criminal Justice Testing
    • 7.3.3. Work Place Screening

8. Global Drugs - of - Abuse Testing Market Analysis and Forecast, By End User

  • 8.1. Introduction
  • 8.2. Market Revenue Share (US$) and Attractiveness Analysis, By End User
  • 8.3. Market Size (US$ Mn) Forecast, By End User
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostics Laboratories
    • 8.3.3. On-the-spot Testing
    • 8.3.4. Forensic Laboratories

9. Global Drugs - of - Abuse Testing Market Analysis and Forecast, By Region

  • 9.1. Market Revenue Share (US$) and Attractiveness Analysis, By Region
  • 9.2. Market Size (US$ Mn) Forecast, By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East and Africa

10. North Drugs - of - Abuse Testing Market Analysis and Forecast

  • 10.1. Market Overview
    • 10.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2024
    • 10.1.2. Testing Market Attractiveness Analysis, by Country
  • 10.2. Market Value Share Analysis by Product Type
    • 10.2.1. Analyzers
      • 10.2.1.1. Immunoassay Analyzers
      • 10.2.1.2. Chromatographic Devices
      • 10.2.1.3. Breath Analyzers
    • 10.2.2. Rapid Testing Devices
      • 10.2.2.1. Urine Testing Devices
      • 10.2.2.2. Oral Fluid Testing Devices
    • 10.2.3. Consumables
      • 10.2.3.1. Fluid Collection Devices
      • 10.2.3.2. Others Sub-mucosal Fibroids
  • 10.3. Market Value Share Analysis by Sample Type
    • 10.3.1. Saliva
    • 10.3.2. Breath
    • 10.3.3. Urine
    • 10.3.4. Blood
    • 10.3.5. Hair & Sweat
  • 10.4. Market Value Share Analysis by Testing Type
    • 10.4.1. Pain Management
    • 10.4.2. Criminal Justice Testing
    • 10.4.3. Work Place Screening
  • 10.5. Market Value Share Analysis by End User
    • 10.5.1. Hospitals
    • 10.5.2. Diagnostics Laboratories
    • 10.5.3. On - the - Spot Testing
    • 10.5.4. Forensic Laboratories
  • 10.6. Market Value Share Analysis by Country
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Size (US$ Mn) Forecast
    • 10.7.1. By Product Type
    • 10.7.2. By Sample Type
    • 10.7.3. By Testing Type
    • 10.7.4. By End User
    • 10.7.5. By Country
  • 10.8. Market Attractiveness Analysis
    • 10.8.1. By Product Type
    • 10.8.2. By Sample Type
    • 10.8.3. By Testing Type
    • 10.8.4. By End User

11. Latin America Drugs - of - Abuse Testing Market Analysis and Forecast

  • 11.1. Market Overview
    • 11.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2024
    • 11.1.2. Testing Market Attractiveness Analysis, by Country
  • 11.2. Market Value Share Analysis by Product Type
    • 11.2.1. Analyzers
      • 11.2.1.1. Immunoassay Analyzers
      • 11.2.1.2. Chromatographic Devices
      • 11.2.1.3. Breath Analyzers
    • 11.2.2. Rapid Testing Devices
      • 11.2.2.1. Urine Testing Devices
      • 11.2.2.2. Oral Fluid Testing Devices
    • 11.2.3. Consumables
      • 11.2.3.1. Fluid Collection Devices
      • 11.2.3.2. Others Sub-mucosal Fibroids
  • 11.3. Market Value Share Analysis by Sample Type
    • 11.3.1. Saliva
    • 11.3.2. Breath
    • 11.3.3. Urine
    • 11.3.4. Blood
    • 11.3.5. Hair & Sweat
  • 11.4. Market Value Share Analysis by Testing Type
    • 11.4.1. Pain Management
    • 11.4.2. Criminal Justice Testing
    • 11.4.3. Work Place Screening
  • 11.5. Market Value Share Analysis by End User
    • 11.5.1. Hospitals
    • 11.5.2. Diagnostics Laboratories
    • 11.5.3. On - the - Spot Testing
    • 11.5.4. Forensic Laboratories
  • 11.6. Market Value Share Analysis by Country
    • 11.6.1. Mexico
    • 11.6.2. Brazil
    • 11.6.3. Rest of Latin America
  • 11.7. Market Size (US$ Mn) Forecast
    • 11.7.1. By Product Type
    • 11.7.2. By Sample Type
    • 11.7.3. By Testing Type
    • 11.7.4. By End User
    • 11.7.5. By Country
  • 11.8. Market Attractiveness Analysis
    • 11.8.1. By Product Type
    • 11.8.2. By Sample Type
    • 11.8.3. By Testing Type
    • 11.8.4. By End User

12. Europe Drugs - of - Abuse Testing Market Analysis and Forecast

  • 12.1. Market Overview
    • 12.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2024
    • 12.1.2. Testing Market Attractiveness Analysis, by Country
  • 12.2. Market Value Share Analysis by Product Type
    • 12.2.1. Analyzers
      • 12.2.1.1. Immunoassay Analyzers
      • 12.2.1.2. Chromatographic Devices
      • 12.2.1.3. Breath Analyzers
    • 12.2.2. Rapid Testing Devices
      • 12.2.2.1. Urine Testing Devices
      • 12.2.2.2. Oral Fluid Testing Devices
    • 12.2.3. Consumables
      • 12.2.3.1. Fluid Collection Devices
      • 12.2.3.2. Others Sub-mucosal Fibroids
  • 12.3. Market Value Share Analysis by Sample Type
    • 12.3.1. Saliva
    • 12.3.2. Breath
    • 12.3.3. Urine
    • 12.3.4. Blood
    • 12.3.5. Hair & Sweat
  • 12.4. Market Value Share Analysis by Testing Type
    • 12.4.1. Pain Management
    • 12.4.2. Criminal Justice Testing
    • 12.4.3. Work Place Screening
  • 12.5. Market Value Share Analysis by End User
    • 12.5.1. Hospitals
    • 12.5.2. Diagnostics Laboratories
    • 12.5.3. On - the - Spot Testing
    • 12.5.4. Forensic Laboratories
  • 12.6. Market Value Share Analysis by Country
    • 12.6.1. U.K.
    • 12.6.2. France
    • 12.6.3. Germany
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Russia
    • 12.6.7. Rest of Europe
  • 12.7. Market Size (US$ Mn) Forecast
    • 12.7.1. By Product Type
    • 12.7.2. By Sample Type
    • 12.7.3. By Testing Type
    • 12.7.4. By End User
    • 12.7.5. By Country
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Product Type
    • 12.8.2. By Sample Type
    • 12.8.3. By Testing Type
    • 12.8.4. By End User

13. APAC Drugs - of - Abuse Testing Market Analysis and Forecast

  • 13.1. Market Overview
    • 13.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2024
    • 13.1.2. Testing Market Attractiveness Analysis, by Country
  • 13.2. Market Value Share Analysis by Product Type
    • 13.2.1. Analyzers
      • 13.2.1.1. Immunoassay Analyzers
      • 13.2.1.2. Chromatographic Devices
      • 13.2.1.3. Breath Analyzers
    • 13.2.2. Rapid Testing Devices
      • 13.2.2.1. Urine Testing Devices
      • 13.2.2.2. Oral Fluid Testing Devices
    • 13.2.3. Consumables
      • 13.2.3.1. Fluid Collection Devices
      • 13.2.3.2. Others Sub-mucosal Fibroids
  • 13.3. Market Value Share Analysis by Sample Type
    • 13.3.1. Saliva
    • 13.3.2. Breath
    • 13.3.3. Urine
    • 13.3.4. Blood
    • 13.3.5. Hair & Sweat
  • 13.4. Market Value Share Analysis by Testing Type
    • 13.4.1. Pain Management
    • 13.4.2. Criminal Justice Testing
    • 13.4.3. Work Place Screening
  • 13.5. Market Value Share Analysis by End User
    • 13.5.1. Hospitals
    • 13.5.2. Diagnostics Laboratories
    • 13.5.3. On - the - Spot Testing
    • 13.5.4. Forensic Laboratories
  • 13.6. Market Value Share Analysis by Country
    • 13.6.1. Japan
    • 13.6.2. China
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of APAC
  • 13.7. Market Size (US$ Mn) Forecast
    • 13.7.1. By Product Type
    • 13.7.2. By Sample Type
    • 13.7.3. By Testing Type
    • 13.7.4. By End User
    • 13.7.5. By Country
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Product Type
    • 13.8.2. By Sample Type
    • 13.8.3. By Testing Type
    • 13.8.4. By End User

14. MEA Drugs - of - Abuse Testing Market Analysis and Forecast

  • 14.1. Market Overview
    • 14.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2024
    • 14.1.2. Testing Market Attractiveness Analysis, by Country
  • 14.2. Market Value Share Analysis by Product Type
    • 14.2.1. Analyzers
      • 14.2.1.1. Immunoassay Analyzers
      • 14.2.1.2. Chromatographic Devices
      • 14.2.1.3. Breath Analyzers
    • 14.2.2. Rapid Testing Devices
      • 14.2.2.1. Urine Testing Devices
      • 14.2.2.2. Oral Fluid Testing Devices
    • 14.2.3. Consumables
      • 14.2.3.1. Fluid Collection Devices
      • 14.2.3.2. Others Sub-mucosal Fibroids
  • 14.3. Market Value Share Analysis by Sample Type
    • 14.3.1. Saliva
    • 14.3.2. Breath
    • 14.3.3. Urine
    • 14.3.4. Blood
    • 14.3.5. Hair & Sweat
  • 14.4. Market Value Share Analysis by Testing Type
    • 14.4.1. Pain Management
    • 14.4.2. Criminal Justice Testing
    • 14.4.3. Work Place Screening
  • 14.5. Market Value Share Analysis by End User
    • 14.5.1. Hospitals
    • 14.5.2. Diagnostics Laboratories
    • 14.5.3. On - the - Spot Testing
    • 14.5.4. Forensic Laboratories
  • 14.6. Market Value Share Analysis by Country
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of MEA
  • 14.7. Market Size (US$ Mn) Forecast
    • 14.7.1. By Product Type
    • 14.7.2. By Sample Type
    • 14.7.3. By Testing Type
    • 14.7.4. By End User
    • 14.7.5. By Country
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Product Type
    • 14.8.2. By Sample Type
    • 14.8.3. By Testing Type
    • 14.8.4. By End User

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix
  • 15.2. Market Share Analysis By Company (2015)
  • 15.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 15.3.1. F. Hoffmann La-Roche Ltd
      • 15.3.1.1. Company Details
      • 15.3.1.2. Company Description
      • 15.3.1.3. Business Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Siemens Healthineers (Siemens AG)
      • 15.3.2.1. Company Details
      • 15.3.2.2. Company Description
      • 15.3.2.3. Business Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Thermo Fisher Scientific, Inc.
      • 15.3.3.1. Company Details
      • 15.3.3.2. Company Description
      • 15.3.3.3. Business Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Alere, Inc.
      • 15.3.4.1. Company Details
      • 15.3.4.2. Company Description
      • 15.3.4.3. Business Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Shimadzu Corporation
      • 15.3.5.1. Company Details
      • 15.3.5.2. Company Description
      • 15.3.5.3. Business Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Laboratory Corporation of America Holdings
      • 15.3.6.1. Company Details
      • 15.3.6.2. Company Description
      • 15.3.6.3. Business Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Drägerwerk AG & Co. KGaA
      • 15.3.7.1. Company Details
      • 15.3.7.2. Company Description
      • 15.3.7.3. Business Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Express Diagnostics International Inc.
      • 15.3.8.1. Company Details
      • 15.3.8.2. Company Description
      • 15.3.8.3. Business Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview

List of Figures

  • Figure 1: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 2: Global Drug of Abuse Testing Market Value Share By Product Type (2016)
  • Figure 3: Global Drug of Abuse Testing Market Value Share By Sample Type (2016)
  • Figure 4: Global Drug of Abuse Testing Market Value Share By Testing Type (2016)
  • Figure 5: Global Drug of Abuse Testing Market Value Share By End User (2016)
  • Figure 6: Global Drug of Abuse Testing Market Value Share By Region (2016)
  • Figure 7: Global Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
  • Figure 8: Global Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
  • Figure 9: Global Analyzers Market Revenue (US$ Mn) 2016-2024
  • Figure 10: Global Rapid Testing Devices Market Revenue (US$ Mn), 2016-2024
  • Figure 11: Global Consumables Market Revenue (US$ Mn) 2016-2024
  • Figure 12: Global Drug of Abuse Testing Market Value Share Analysis By Sample Type, 2016 and 2024
  • Figure 13: Global Drug of Abuse Testing Market Attractiveness Analysis By Sample Type, 2015
  • Figure 14: Global Saliva Market Revenue (US$ Mn) 2016-2024
  • Figure 15: Global Breath Market Revenue (US$ Mn), 2016-2024
  • Figure 16: Global Urine Market Revenue (US$ Mn), 2016-2024
  • Figure 17: Global Blood Market Revenue (US$ Mn), 2016-2024
  • Figure 18: Global Hair and Sweat Market Revenue (US$ Mn), 2016-2024
  • Figure 19: Global Drug of Abuse Testing Market Value Share Analysis, by Testing Type, 2016 and 2024
  • Figure 20: Global Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
  • Figure 21: Global Pain Management Testing Market Revenue (US$ Mn) 2016-2024
  • Figure 22: Global Criminal Justice Testing Market Revenue (US$ Mn), 2016-2024
  • Figure 23: Global Work Place Screening Market Revenue (US$ Mn) 2016-2024
  • Figure 24: Global Drug of Abuse Testing Market Value Share Analysis, by End User, 2016 and 2024
  • Figure 25: Global Drug of Abuse Testing Market Attractiveness Analysis, by End User, 2015
  • Figure 26: Global Hospital Market Revenue (US$ Mn) 2016-2024
  • Figure 27: Global Diagnostic Laboratories Market Revenue (US$ Mn), 2016-2024
  • Figure 28: Global On-the-spot Testing Market Revenue (US$ Mn) 2016-2024
  • Figure 29: Global Forensic Laboratories Market Revenue (US$ Mn), 2016-2024
  • Figure 30: Global Drug of Abuse Testing Market Value Share Analysis By Region, 2016 and 2024
  • Figure 31: Global Drug of Abuse Testing Market Attractiveness Analysis, By Region, 2015
  • Figure 32: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2024
  • Figure 33: North America Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
  • Figure 34: North America Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
  • Figure 35: North America Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
  • Figure 36: North America Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
  • Figure 37: North America Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
  • Figure 38: North America Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 39: North America Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
  • Figure 40: North America Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
  • Figure 41: North America Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
  • Figure 42: North America Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
  • Figure 43: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2024
  • Figure 44: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
  • Figure 45: Latin America Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
  • Figure 46: Latin America Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
  • Figure 47: Latin America Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
  • Figure 48: Latin America Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
  • Figure 49: Latin America Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 50: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
  • Figure 51: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
  • Figure 52: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
  • Figure 53: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
  • Figure 54: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2024
  • Figure 55: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
  • Figure 56: Europe Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
  • Figure 57: Europe Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
  • Figure 58: Europe Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
  • Figure 59: Europe Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
  • Figure 60: Europe Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 61: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
  • Figure 62: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
  • Figure 63: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
  • Figure 64: Europe Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
  • Figure 65: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2024
  • Figure 66: APAC Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
  • Figure 67: APAC Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
  • Figure 68: APAC Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
  • Figure 69: APAC Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
  • Figure 70: APAC Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
  • Figure 71: APAC Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 72: APAC Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
  • Figure 73: APAC Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
  • Figure 74: APAC Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
  • Figure 75: APAC Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
  • Figure 76: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2024
  • Figure 77: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
  • Figure 78: MEA Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
  • Figure 79: MEA Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
  • Figure 80: MEA Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
  • Figure 81: MEA Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
  • Figure 82: MEA Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 83: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
  • Figure 84: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
  • Figure 85: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
  • Figure 86: MEA Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
  • Figure 87: Global Drugs - of - Abuse Testing Market, Company Share Analysis, 2015
  • Figure 81: MEA Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
  • Figure 82: MEA Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 83: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015

List of Tables

  • Table 1: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By Product Type, 2016-2024 (1/2)
  • Table 2: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By Sample Type, 2016-2024
  • Table 3: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By Testing Type, 2016-2024
  • Table 4: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By End User, 2016-2024
  • Table 5: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By Region, 2016-2024
  • Table 6: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016-2024
  • Table 7: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016-2024
  • Table 8: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016-2024
  • Table 9: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016-2024
  • Table 10: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016-2024
  • Table 11: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016-2024
  • Table 12: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016-2024
  • Table 13: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016-2024
  • Table 14: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016-2024
  • Table 15: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016-2024
  • Table 16: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016-2024 (1/2)
  • Table 17: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016-2024
  • Table 18: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016-2024
  • Table 19: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016-2024
  • Table 20: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016-2024
  • Table 21: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016-2024
  • Table 22: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016-2024
  • Table 23: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016-2024
  • Table 24: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016-2024
  • Table 25: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016-2024
  • Table 26: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016-2024
  • Table 27: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016-2024
  • Table 28: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016-2024
  • Table 29: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016-2024
  • Table 30: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016-2024
Back to Top